DCF — BELLEVUE MEDICAL CENTER
Enterprise Value: $109.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$109.2M
Enterprise Value
$29.3M
PV of Cash Flows
$79.9M
PV of Terminal Value
$128.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $116.2M | $13.5M | 12.0% | $6.0M | $5.4M |
| Year 2 | $119.7M | $15.1M | 13.0% | $7.0M | $5.8M |
| Year 3 | $123.2M | $16.8M | 14.0% | $8.2M | $6.1M |
| Year 4 | $126.9M | $18.0M | 14.0% | $8.9M | $6.1M |
| Year 5 | $130.7M | $18.8M | 14.0% | $9.4M | $5.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $109.2M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$112.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.11160879796471829
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5